Improved bone status by the β-blocker propranolol in an animal model of nutritional growth retardation

British Journal of Nutrition

Volumn 101, Issue 11, 2009, Pages 1616-1620

  Lezón, Christian E ^a   Olivera, María I ^a   Bozzini, Clarisa ^a   Mandalunis, Patricia ^a   Alippi, Rosa M ^a   Boyer, Patricia M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Bone histomorphometry; Mechanical performance; Nutritional growth retardation; Propranolol

Indexed keywords

PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY HEIGHT; BODY WEIGHT; BONE DISEASE; BONE GROWTH; BONE MASS; BONE STRUCTURE; CONTROLLED STUDY; DIAPHYSIS; FEMUR; FOOD INTAKE; GROWTH PLATE; GROWTH RETARDATION; MALE; MALNUTRITION; NONHUMAN; NUTRITIONAL GROWTH RETARDATION; RAT; TIBIA; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BONE AND BONES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMUR; FOOD DEPRIVATION; GROWTH DISORDERS; MALE; MODELS, ANIMAL; PROPRANOLOL; RATS; RATS, WISTAR; STRESS, MECHANICAL; WEIGHT-BEARING;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 67649425366     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450811145X     Document Type: Article

References (28)

1. Hill PA & Orth M (1998) Bone remodeling. BJO 25, 101-107.
2. Amling M, Takeda S & Karsenty G (2000) A neuro (endo)crine regulation of bone remodeling. BioEssays 22, 970-975.
3. Takeda S & Karsenty G (2001) Central control of bone formation. J Bone Miner Metab 19, 195-198.
4. Takeda S (2008) Central control of bone remodelling. J Neuroendocrinol 20, 802-807.
5. Elefteriou F (2008) Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 15, 231-236.
6. Turner CH & Burr DB (1993) Basic biomechanical measurements of bone: A tutorial. Bone 14, 595-608.
7. Ferretti JL (1997) Biomechanical properties of bone. In Osteoporosis and Bone Densitometry, pp. 143-161 [HK Gennant, G Guglielmi and M Jergas, editors]. Berlin: Springer Verlag.
8. Togari A, Arai M, Mizutani S, et al. (1997) Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 233, 125-128.
9. Togari A (2002) Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58, 77-84.
10. Takeda S, Elefteriou F, Levasseur R, et al. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317.
11. Minkowitz B, Boskey AL, Lane JM, et al. (1991) Effects of propranolol on bone metabolism in the rat. J Orthop Res 9, 869-875.
12. Bonjour JP, Ammann P, Chevalley T, et al. (2001) Protein intake and bone growth. Can J Appl Physiol 26, 153-166.
13. Boyer PM, Compagnucci GE, Olivera MI, et al. (2005) Bone status in an animal model of chronic sub-optimal nutrition: A morphometric, densitometric and mechanical study. Br J Nutr 93, 663-669.
14. Kaplan RM & Toshima MT (1992) Does a reduced fat diet cause retardation in child growth? Prev Med 21, 33-52.
15. Akeson PK, Axelsson IEM, Raiha NCR, et al. (2000) Fat intake and metabolism in Swedish and Italian infants. Acta Paediatr 89, 28-33.
16. Lifshitz F & Moses N (1989) Growth failure: A complication of dietary treatment of hypercholesterolemia. Am J Dis Child 143, 537-542.
17. Friedman SM, Rodriguez PN, Olivera MI, et al. (1998) Enanismo por desnutrición: Cronodinamia de los procesos metabólicos en ratas (Nutritional dwarfing: Longitudinal analysis of anthropometric and metabolic parameters in rats). Medicina (B Aires) 58, 282-286.
18. Parfitt AM, Drezner MK, Glorieux FH, et al. (1987) Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2, 595-610.
19. Sokal R & Rohlf J (1994) Biometry: The Principles and Practice of Statistics in Biological Research. San Francisco: WH Freeman & Co.
20. Pugliese MT, Weyman-Daum M, Moses N, et al. (1987) Parental health beliefs as a cause of nonorganic failure to thrive. Pediatrics 80, 175-182.
21. Lifshitz F & Moses N (1988) Nutritional dwarfing: Growth, dieting and fear of obesity. J Am Coll Nutr 7, 367-376.
22. Keller W & Fillmore CM (1983) Prevalence of protein-energy malnutrition. World Health Stat Q 36, 129-167.
23. Boyce BF & Xing L (2007) Review. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9, Suppl. 1, S1.
24. Takeda S, Elefteriou F, Levasseur R, et al. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317.
25. Elefteriou F, Ahn JD, Takeda S, et al. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514-520.
26. Bonnet N, Pierroz DD & Ferrari SL (2008) Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact 8, 94-104.
27. Bonnet N, Laroche N, Vico L, et al. (2006) Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther 318, 1118-1127.
28. Scott CK & Hightower JA (1991) The matrix of endochondral bone differs from the matrix of intramembranous bone. Calcif Tissue Int 49 349-354.